
Silence Therapeutics plc (SLN)
Trading disclosure
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for certain activity generated through this link. Prices displayed are informational.
Learn more- Previous Close
19.67 - Open
19.65 - Bid 7.92 x 200
- Ask 14.22 x 200
- Day's Range
19.62 - 19.68 - 52 Week Range
4.19 - 19.68 - Volume
3,078,425 - Avg. Volume
2,580,423 - Market Cap (intraday)
1.222B - Beta (5Y Monthly) 1.45
- PE Ratio (TTM)
-- - EPS (TTM)
-1.29 - Earnings Date (est.) Nov 5, 2026
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
19.75 - Zacks Rating Bullish
Recent News
View MorePerformance Overview
Trailing total returns as of 10/22/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
745.85M
-
Enterprise Value
673.91M
-
Trailing P/E
--
-
Forward P/E
--
-
PEG Ratio (5yr expected)
--
-
Price/Sales (ttm)
884.02
-
Price/Book (mrq)
18.60
-
Enterprise Value/Revenue
1.10k
-
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-29.65%
-
Return on Equity (ttm)
-90.41%
-
Revenue (ttm)
615k
-
Net Income Avi to Common (ttm)
-59.95M
-
Diluted EPS (ttm)
-1.29
Balance Sheet and Cash Flow
-
Total Cash (mrq)
72.05M
-
Total Debt/Equity (mrq)
0.29%
-
Levered Free Cash Flow (ttm)
-23.57M
Compare
Select to analyze similar companies using key performance metrics; select up to 4 stocks.










